|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o Agennix Inc., of Houston, said it completed the safety portions of two Phase I/II cancer trials of recombinant human lactoferrin with the Department of Hematology/Oncology at the Veterans Affairs Medical Center in Houston. The trials are in the U.S. and South America. Lactoferrin is a protein found naturally in milk and other exocrine secretions and is believed to play a role in the immune system. The trials are evaluating the product as a single agent for the treatment of solid tumors in patients who progressed on standard chemotherapy and whose tumors were not resectable. Thirty patients were enrolled in the safety phase. In the ongoing efficacy phase, an additional 38 ...